6533b855fe1ef96bd12b0015
RESEARCH PRODUCT
Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs.
Esther Lázaro-pérezMaria Jesús Pascual-cascónRoberto Nuño-solinísMarino J. GonzálezFrancesc Fernández-avilésMi KwonCristina GallegoLourdes VázquezMaider Urtaran-laresgoitiCarlos SolanoElena Urizarsubject
Cell Transplantationmedicine.medical_treatmentFeversHematopoietic stem cell transplantationHealth careOutpatientsMedicine and Health SciencesBlood and Lymphatic System ProceduresOutpatient clinicMultidisciplinaryMortality rateQRHematopoietic Stem Cell TransplantationHematopoietic stem cellResearch AssessmentHospitalsSurvival Ratemedicine.anatomical_structureSystematic reviewModels EconomicCosts and Cost AnalysisMedicineResearch Articlemedicine.medical_specialtyPatientsSystematic ReviewsDeath RatesScienceSurgical and Invasive Medical ProceduresHealth outcomesResearch and Analysis MethodsTransplantation AutologousDisease-Free SurvivalQuality of life (healthcare)Signs and SymptomsPopulation MetricsmedicineHumansTransplantation HomologousIntensive care medicineOutpatient ClinicsTransplantationInpatientsPopulation Biologybusiness.industryBiology and Life SciencesLength of StayHealth CareHealth Care FacilitiesQuality of LifeClinical MedicinebusinessStem Cell Transplantationdescription
The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in-hospital and outpatient models for autologous and allogeneic HSCT using the Triple Aim framework: health outcomes, costs and experience of care. We found evidence on improved health outcomes and quality of life, on enhanced safety and effectiveness and on reduced overall costs and hospital stays, with similar results on overall survival rates comparing both models for autologous and allogeneic patients. We also found that the outpatient Hematopoietic Stem Cell Transplantation is a safe practice as well as less costly, it requires fewer days of hospital stay both for autologous and allogeneic transplantations. Under a situation of an increasing number of transplants, rising healthcare costs and shortages of hospital capacity, incorporating outpatient models could improve the quality of care for people requiring Hematopoietic Stem Cell Transplantation programs.
year | journal | country | edition | language |
---|---|---|---|---|
2021-08-12 | PloS one |